Signifier Medical Technologies Announces Participation In Morgan Stanley 2019 Global Medtech Conference
London, United Kingdom
July 15, 2019 – Signifier Medical Technologies, a medical technology company developing innovative sleep disordered breathing products for use in the homecare setting, today announced that the Company’s management will be participating in the 2019 Global MedTech conference in New York.
Signifier Medical’s Co-founder and CEO, Akhil Tripathi, and CFO and VP of Business Development, Paolo Asoni are scheduled to present on Monday, September 9, 2019 at 9:55 a.m. ET at the Morgan Stanley 2019 Global MedTech Conference.
About Signifier Medical Technologies
Signifier Medical Technologies, previously known as Snoozeal, is a medical technology company focused on the development and commercialization of innovative and non-invasive solutions for patients with snoring and sleep disordered breathing conditions.
Signifier’s proprietary therapy is the first and only day time genioglossal muscle-neurostimulation technology, with proven clinical data from prestigious and well-recognised universities and academic institutions, that provides a safe and effective treatment for its patients.
For media enquiries:
+44 (0) 207 096 0586